The Absence of Items Addressing Increased Appetite or Weight in Depressive-Symptom Questionnaires: Implications for Understanding the Link between Major Depressive Disorder, Antidepressants, and Obesity
Major depressive disorder (MDD) and obesity have a complex bidirectional relationship. However, most studies do not assess increased appetite or weight as a depressive symptom due to limitations in rating scales. Here we aimed to analyze frequently employed depressive-symptom scales and discuss the relevance of weight and appetite assessment items. To elaborate this perspective, we searched for validated questionnaires and scales evaluating depressive symptoms in English. We analyzed appetite and weight items from 20 depressive-symptoms rating scales. Only 8 of 20 rating scales assessed for increased weight or appetite. The scales reported in the literature as the most employed in antidepressants efficacy trials do not assess increased appetite or weight. The current use of rating scales limits our understanding of the relationship between MDD, antidepressants, and obesity. It is necessary to improve our weight and appetite measurements in MDD to clarify the respective impact of depressive symptoms and antidepressants on weight change.
Authors
- Marci E. Gluck (ORCID: https://orcid.org/0000-0002-6284-9953)
- Alfredo B. Cuéllar‐Barboza (ORCID: https://orcid.org/0000-0002-7663-913X)
- Andrés M. Treviño‐Alvarez (ORCID: https://orcid.org/0000-0001-9405-3338)
- Susan L. McElroy
Institutions
- National Institutes of Health (US)
- Mayo Clinic (US)
- Universidad Autónoma de Nuevo León (MX)
- WinnMed (US)
- National Institute of Diabetes and Digestive and Kidney Diseases (US)
- Lindner Center of HOPE (US)
- Mayo Clinic Hospital (US)
- University of Cincinnati Medical Center (US)
Publication Details
- Journal
- Brain Sciences
- Published
- 2024-08-21
- DOI
- https://doi.org/10.3390/brainsci14080841
- Citations
- 4
- Primary Topic
- Diet and metabolism studies
- Type
- article
- Field-Weighted Citation Impact
- 1.31
Funders
- University of Cincinnati
- Sunovion
- J. Willard and Alice S. Marriott Foundation
- Novo Nordisk
- Idorsia Pharmaceuticals
- National Institute of Mental Health